Signed agreement with Zoetis for distribution of the CLARIFIDE genomic test
Saint-Hyacinthe, April 1, 2016 – Ciaq and Zoetis are pleased to announce the signature of an agreement for the distribution of the CLARIFIDE genomic test in the province of Quebec.
CLARIFIDE uses DNA-marker technology for optimizing selection and management of Holstein, Jersey and Brown Swiss females.
Genomic technology is having a significant impact in Canadian dairy farms by helping breeders to achieve their genetic improvement objectives more quickly and efficiently.
With CLARIFIDE, Ciaq consultants will assist producers who wish to integrate genomics into their herd management strategy, by assisting them with sample collection, result interpretation and developing adapted genetic strategies to satisfy their needs.
Zoetis in cooperation with Ciaq is committed to provide support and training to teams in the field.
Photo (left to right): René Delorme, representative with Zoetis, Paul Thibaudeau, sales coach at Ciaq, Virginie Filteau, chief veterinarian, and Camille Maloney, consultant service representative at Ciaq.